 Forbes | Abbott's Xience Prime nets FDA clearance Cardiovascular Business Abbott has received FDA approval for the next-generation Xience Prime everolimus-eluting coronary stent system for the treatment of coronary artery disease. Xience Prime uses the same drug and biocompatible polymer as the Xience V everolimus-eluting ... FDA Approves Abbott's Xience Prime Drug-Eluting Stent Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug ... FDA Approves Xience Prime Stent |
